Biomarin Pharmaceutical Inc (NASDAQ: BMRN)’s stock price has plunge by 0.48relation to previous closing price of 64.69. Nevertheless, the company has seen a -1.90% plunge
The stock of Biomarin Pharmaceutical Inc (BMRN) has seen a 0.15% increase in the past week, with a 0.20% gain in the past month, and
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) has a higher price-to-earnings ratio of 39.39x compared to its average ratio. BMRN has 36-month beta value of 0.29. Analysts
The price-to-earnings ratio for Biomarin Pharmaceutical Inc (NASDAQ: BMRN) is above average at 39.39x, Company’s 36-month beta value is 0.29.Analysts have differing opinions on the
The stock of Biomarin Pharmaceutical Inc (BMRN) has seen a -6.29% decrease in the past week, with a -11.82% drop in the past month, and
The stock price of Biomarin Pharmaceutical Inc (NASDAQ: BMRN) has jumped by 0.80 compared to previous close of 66.13. Despite this, the company has seen
© 2024, Powered by Smart TechOne
